In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy

TY - JOUR

T1 - In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy

AU - Chinuki, Yuko

AU - Yagami, Akiko

AU - Adachi, Atsuko

AU - Matsunaga, Kayoko

AU - Ugajin, Tsukasa

AU - Yokozeki, Hiroo

AU - Hayashi, Misa

AU - Katayama, Ichiro

AU - Kohno, Kunie

AU - Shiwaku, Kuninori

AU - Morita, Eishin

N1 - Funding Information: This study was supported by Health Labour Sciences Research Grant and the foundation established by Yuka K.K., Phoenix K.K., and Katayama Kagaku Kogyo Institute K.K. in Research Center for Prevention of Lifestyle related Disease. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: This study was supported by Health Labour Sciences Research Grant and the foundation established by Yuka K.K. Phoenix K.K. and Katayama Kagaku Kogyo Institute K.K. in Research Center for Prevention of Lifestyle related Disease. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: YC received lecture fees and grant support from Novartis. AY received lecture fees from Novartis. The rest of the authors have no conflict of interest.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85082412954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082412954&partnerID=8YFLogxK

U2 - 10.1016/j.alit.2019.09.006

DO - 10.1016/j.alit.2019.09.006

M3 - Letter

C2 - 31753713

AN - SCOPUS:85082412954

SN - 1323-8930

VL - 69

SP - 284

EP - 286

JO - Allergology International

JF - Allergology International

IS - 2

ER -